Mohamed Elsnoussi Ali, Ahmad Mariam, Ang Lee Fung, Asmawi Mohd Zaini, Yam Mun Fei
School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Penang, Malaysia.
Evid Based Complement Alternat Med. 2015;2015:754931. doi: 10.1155/2015/754931. Epub 2015 Nov 16.
In the present study, a 50% ethanolic extract of Orthosiphon stamineus was tested for its α-glucosidase inhibitory activity. In vivo assays of the extract (containing 1.02%, 3.76%, and 3.03% of 3'hydroxy-5,6,7,4'-tetramethoxyflavone, sinensetin, and eupatorin, resp.) showed that it possessed an inhibitory activity against α-glucosidase in normal rats loaded with starch and sucrose. The results showed that 1000 mg/kg of the 50% ethanolic extract of O. stamineus significantly (P < 0.05) decreased the plasma glucose levels of the experimental animals in a manner resembling the effect of acarbose. In streptozotocin-induced diabetic rats, only the group treated with 1000 mg/kg of the extract showed significantly (P < 0.05) lower plasma glucose levels after starch loading. Hence, α-glucosidase inhibition might be one of the mechanisms by which O. stamineus extract exerts its antidiabetic effect. Furthermore, our findings indicated that the 50% ethanolic extract of O. stamineus can be considered as a potential agent for the management of diabetes mellitus.
在本研究中,对猫须草的50%乙醇提取物进行了α-葡萄糖苷酶抑制活性测试。该提取物的体内试验(分别含有3'-羟基-5,6,7,4'-四甲氧基黄酮、华良姜素和泽兰苦内酯1.02%、3.76%和3.03%)表明,它对淀粉和蔗糖负荷的正常大鼠体内的α-葡萄糖苷酶具有抑制活性。结果显示,1000mg/kg的猫须草50%乙醇提取物能显著(P<0.05)降低实验动物的血糖水平,其作用方式类似于阿卡波糖。在链脲佐菌素诱导的糖尿病大鼠中,只有用1000mg/kg提取物处理的组在淀粉负荷后血糖水平显著(P<0.05)降低。因此,α-葡萄糖苷酶抑制可能是猫须草提取物发挥抗糖尿病作用的机制之一。此外,我们的研究结果表明,猫须草的50%乙醇提取物可被视为一种治疗糖尿病的潜在药物。